Read, Watch or Listen

The FDA has approved a second generic version of the abortion pill mifepristone. This routine regulatory action has drawn criticism from anti-abortion groups and some Republican politicians, who view it as a "deep state" move. The FDA stated it has limited discretion in approving generics and does not endorse any product. While access is restricted by state laws, the approval is unlikely to change the pill's availability. The drugmaker plans to launch its version next January.

Prepared by Lauren Mitchell and reviewed by editorial team.